Corinna Sorenson, PhD

Assistant Professor in Population Health Sciences
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Email address corinna.sorenson@duke.edu

Dr. Sorenson has extensive research and policy expertise in value assessment in health care, comparative effectiveness research, drug and device regulation and payment, and health policy evaluation. She is interested in the design, implementation, and assessment of innovative, evidence-based strategies to enhance value-based health care, particularly with regards to new and existing health care treatments and services. In this work, she also examines the economic, methodological, political, cultural, organizational, professional, and legal levers that support or hinder the adoption of such approaches.     

Dr. Sorenson’s work also focuses on education and training development in health policy and management. She is currently Faculty Director of Graduate Education Initiatives and the Margolis Scholars in Health Policy and Management Program at the Duke-Margolis Center for Health Policy. 

Outside of academe, Dr. Sorenson has served in senior health care consulting and policy positions in both the private and public sectors. She has also worked in an advisory capacity for governmental organizations in several countries on development of national and regional health technology assessment systems.  

Education and Training

  • Ph.D., London School of Economics (UK), 2015

Publications

Mahendraratnam, Nirosha, Corinna Sorenson, Elizabeth Richardson, Gregory W. Daniel, Lisabeth Buelt, Kimberly Westrich, Jingyuan Qian, Hilary Campbell, Mark McClellan, and Robert W. Dubois. “Value-based arrangements may be more prevalent than assumed..” Am J Manag Care 25, no. 2 (February 2019): 70–76.

PMID
30763037
Scholars@Duke

Sorenson, Corinna, Gabriela Lavezzari, Gregory Daniel, Randy Burkholder, Marc Boutin, Edmund Pezalla, Gillian Sanders, and Mark McClellan. “Advancing Value Assessment in the United States: A Multistakeholder Perspective..” Value Health 20, no. 2 (February 2017): 299–307. https://doi.org/10.1016/j.jval.2016.11.030.

PMID
28237214
Full Text

Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada and the UK. What Can We Learn From International Experience?.” In Pharmacoeconomics From Theory to Practice. CRC Press, 2016.

Scholars@Duke

Sorenson, Corinna, Michael Drummond, Aleksandra Torbica, Giuditta Callea, and Ceu Mateus. “The role of hospital payments in the adoption of new medical technologies: an international survey of current practice.” Health Economics, Policy and Law 10, no. 2 (April 2015): 133–59. https://doi.org/10.1017/s1744133114000358.

Full Text

SORENSON, C. O. R. I. N. N. A., and M. I. C. H. A. E. L. DRUMMOND. “Improving Medical Device Regulation: The United States and Europe in Perspective.” Milbank Quarterly 92, no. 1 (March 2014): 114–50. https://doi.org/10.1111/1468-0009.12043.

Full Text

Sorenson, C., M. K. Gusmano, and A. Oliver. “The Politics of Comparative Effectiveness Research: Lessons from Recent History.” Journal of Health Politics, Policy and Law 39, no. 1 (January 1, 2014): 139–70. https://doi.org/10.1215/03616878-2395199.

Full Text

Sorenson, Corinna, Michael Drummond, and Grahame Wilkinson. “Use of innovation payments to encourage the adoption of new medical technologies in the English NHS.” Health Policy and Technology 2, no. 3 (September 2013): 168–73. https://doi.org/10.1016/j.hlpt.2013.05.001.

Full Text

Sorenson, C., M. Drummond, and L. R. Burns. “Getting To Better Value From Medical Devices: Reimbursement And Pricing Policies In Europe And The United States.” Value in Health 16, no. 3 (May 2013): A249–A249. https://doi.org/10.1016/j.jval.2013.03.1268.

Full Text

Sorenson, Corinna, Michael Drummond, and Lawton R. Burns. “Evolving Reimbursement And Pricing Policies For Devices In Europe And The United States Should Encourage Greater Value.” Health Affairs 32, no. 4 (April 2013): 788–96. https://doi.org/10.1377/hlthaff.2012.1210.

Full Text

Pages